Celanese (CE) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
16 Jan, 2026Executive summary
Q3 2024 net sales were $2.65B, down 3% year-over-year, with persistent demand weakness in auto, industrial, paints, coatings, and construction end-markets.
Operating profit for Q3 2024 was $248M, a 71% decrease from Q3 2023, mainly due to a prior-year gain from the Nutrinova JV that did not recur.
The company announced a 95% temporary reduction in its quarterly dividend starting Q1 2025 to support deleveraging.
Actions include significant cost reductions, production slowdowns, and a focus on operational excellence and future growth opportunities.
Net earnings attributable to Celanese for Q3 2024 were $116M, down from $951M in Q3 2023; nine-month net earnings were $392M, down from $1.26B.
Financial highlights
Q3 2024 net sales were $2.648B, down from $2.723B in Q3 2023 and flat sequentially.
Gross profit for Q3 2024 was $622M, down from $673M in Q3 2023; operating margin was 9.4% versus 30.9% in Q3 2023.
Adjusted EBIT was $457M, flat year-over-year; operating EBITDA was $644M, up from $624M in Q3 2023.
Free cash flow was $(16)M, with operating cash flow of $79M and $88M in capex.
Cash and cash equivalents as of September 30, 2024, were $813M, down from $1.81B at year-end 2023.
Outlook and guidance
Q4 2024 guidance reflects further earnings decline, driven by seasonality, destocking, and continued weakness in auto and industrial end-markets.
Q4 adjusted EPS guidance is approximately $1.25.
Most one-off impacts in Q4 are expected to reverse in Q1 2025, potentially improving results.
Management is cautious about 2025, citing significant uncertainty in demand recovery and macro conditions.
Capital expenditures for 2024 are expected to be approximately $425M, focused on maintenance, productivity, and select growth projects.
Latest events from Celanese
- Sales and operating profit grew, but financing costs and restructuring drove a $253 million loss.CE
Q4 2004 - Pricing and productivity lifted FY 2005 profit, but leverage and input-cost risks persisted.CE
Q4 2005 - Pricing and productivity lifted FY 2006 operating profit 30.3% to $747M.CE
Q4 2006 - Pricing and currency lifted sales 12%, while outages, costs and refinancing weighed on results.CE
Q4 2007 - Recession cut earnings, but cash improved and recovery was expected in 2010.CE
Q4 2009 - Recovery lifted sales and operating profit; 2011 growth was expected across all segments.CE
Q4 2010 - FY11 earnings grew on pricing and mix, while major capacity and ethanol investments set up the next growth phase.CE
Q4 2011 - Acetyl pricing and currency dragged FY12 results; 12%–14% earnings growth targeted for FY13.CE
Q4 2012 - A $742 million relocation gain drove record reported profit amid mixed segment trends.CE
Q4 2013 - Sales and adjusted EPS advanced as record cash flow funded growth and shareholder returns.CE
Q4 2014